{
    "success": true,
    "data": {
        "id": 1842728,
        "msgid": "not-just-drugs-and-vaccines-kalbe-farmas-expansion-strategy-1783317075",
        "date": "2026-07-06 11:33:13",
        "title": "Not Just Drugs and Vaccines: Kalbe Farma's Expansion Strategy",
        "author": "",
        "source": "CNBC",
        "tags": "",
        "topic": "Business",
        "summary": "PT Kalbe Farma Tbk (KLBF) reported a 10.1% year-on-year revenue growth in the first quarter of 2026, driven by a sustainable healthcare ecosystem. The pharmaceutical giant is expanding beyond curative medicine into preventive and promotive health products, including health foods and multivitamins. Director Mulia Lie highlighted the company's commitment to supporting public health quality through diversified development in the healthcare industry.",
        "content": "<p>Healthcare issuer PT Kalbe Farma Tbk (KLBF) recorded a 10.1%\nyear-on-year revenue growth in the first quarter of 2026, reaching Rp\n9.68 trillion. Director of PT Kalbe Farma Tbk, Mulia Lie, stated that\nthe positive performance amidst global turmoil was inseparable from the\ncompany\u2019s sustainable healthcare ecosystem. Increasing public awareness\nof maintaining health and improvements in healthcare services and\ninfrastructure have become pillars supporting economic growth, including\nthe health sector. Kalbe Farma, in its role supporting efforts to\nimprove the quality of public health in Indonesia, is committed to\ndeveloping healthcare products not only for curative treatment but also\nfor preventive and promotive care, with health foods and multivitamins\nbeing among the segments that continue to grow within the company.<\/p>",
        "url": "https:\/\/jawawa.id\/newsitem\/not-just-drugs-and-vaccines-kalbe-farmas-expansion-strategy-1783317075",
        "image": ""
    },
    "sponsor": "Okusi Associates",
    "sponsor_url": "https:\/\/okusiassociates.com"
}